Efficiency of topical rifampin on infection in open neural tube defects: a randomized controlled trial

References

• Copp AJ, Adzick NS, Chitty LS, et al. Spina bifida. Nat Rev Dis Primers. 2015;1:15007.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Kancherla V, Moorthie S, et al. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci. 2018;1414(1):31–46.
   PubMed Web of Science ®Google Scholar
• Clemmensen D, Rasmussen MM, Mosdal C. A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics. Childs Nerv Syst. 2010;26(11):1517–1521.
   PubMed Web of Science ®Google Scholar
• Lien SC, Maher CO, Garton HJ, et al. Local and regional flap closure in myelomeningocele repair: a 15-year review. Childs Nerv Syst. 2010;26(8):1091–1095.
   PubMed Web of Science ®Google Scholar
• Protzenko T, Bellas A, Pousa MS, et al. Reviewing the prognostic factors in myelomeningocele. Neurosurg Focus. 2019;47(4):E2.
   PubMed Web of Science ®Google Scholar
• Lejus C, Dumont R, Gall CL, et al. A preoperative stay in an intensive care unit is associated with an increased risk of surgical site infection in neonates. J Pediatr Surg. 2013;48(7):1503–1508.
   PubMed Web of Science ®Google Scholar
• Hill BW, Emohare O, Song B, et al. The use of vancomycin powder reduces surgical reoperation in posterior instrumented and noninstrumented spinal surgery. Acta Neurochir (Wien). 2014;156(4):749–754.
   PubMed Web of Science ®Google Scholar
• Demir N, Peker E, Gülşen İ, et al. Powder Topical Rifampin for reducing infections after neural tube defect surgery in infants. World Neurosurg. 2016;95:165–170.
   PubMed Web of Science ®Google Scholar
• Ma H, Cheng J, Peng L, et al. Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis. PLoS One. 2020; 15(3):e0230383.
   PubMed Web of Science ®Google Scholar
• Sari E, Sari S, AkgüN V, et al. Measures of ventricles and evans’ index: from neonate to adolescent. Pediatr Neurosurg. 2015;50(1):12–17.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128–140.
   PubMed Web of Science ®Google Scholar
• Kebriaei MA, Shoja MM, Salinas SM, et al. Shunt infection in the first year of life. PED. 2013;12(1):44–48.
   PubMed Web of Science ®Google Scholar
• Riva-Cambrin J, Kestle JR, Holubkov R, Hydrocephalus Clinical Research Network, et al. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study. J Neurosurg Pediatr. 2016;17(4):382–390.
   PubMed Web of Science ®Google Scholar
• Emohare O, Ledonio CG, Hill BW, et al. Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. Spine J. 2014;14(11):2710–2715.
   PubMed Web of Science ®Google Scholar
• Chiang HY, Herwaldt LA, Blevins AE, et al. Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J. 2014;14(3):397–407.
   PubMed Web of Science ®Google Scholar
• Douthit C, Gudenkauf B, Hamood A, et al. Effects of powdered rifampin and vancomycin solutions on biofilm production of staphylococcus aureus on orthopedic implants. J Clin Orthop Trauma. 2020;11(Suppl 1):S113–S117.
   PubMedGoogle Scholar
• Iselin F, Audren JL, Gouet O, et al. Etude comparée des effets d’un antibiotique et d’un antiseptique locaux en chirurgie d’urgence de la main. Etude contrôlée portant sur 223 patients [Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery]. Ann Chir Main Memb Super. 1990;9(1):65–71.
   PubMedGoogle Scholar
• Weber JM, Sheridan RL, Fagan S, Ryan CM, et al. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population. J Burn Care Res. 2012;33(4):539–543.
   PubMed Web of Science ®Google Scholar
• Butini ME, Cabric S, Trampuz A, et al. In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute. Colloids Surf B Biointerfaces. 2018;161:252–260.
   PubMed Web of Science ®Google Scholar
• Morein B, Abusugra I, Blomqvist G. Immunity in neonates. Vet Immunol Immunopathol. 2002;87(3–4):207–213.
   PubMed Web of Science ®Google Scholar
• Rodrigues AB, Krebs VL, Matushita H, et al. Short-term prognostic factors in myelomeningocele patients. Childs Nerv Syst. 2016;32(4):675–680.
   PubMed Web of Science ®Google Scholar
• Radmanesh F, Nejat F, El Khashab M, et al. Shunt complications in children with myelomeningocele: effect of timing of shunt placement. Clinical article. J Neurosurg Pediatr. 2009;3(6):516–520.
   PubMed Web of Science ®Google Scholar
• Vanaclocha V, Sáiz-Sapena N, Leiva J. Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien). 1996;138(7):829–834.
   PubMed Web of Science ®Google Scholar
• Demir N, Peker E, Gülşen İ, et al. Factors affecting infection development after meningomyelocele repair in newborns and the efficacy of antibiotic prophylaxis. Childs Nerv Syst. 2015;31(8):1355–1359.
   PubMed Web of Science ®Google Scholar
• Schroeder HK, Nunes JC, Madeira L, et al. Postsurgical infection after myelomeningocele repair: a multivariate analysis of 60 consecutive cases. Clin Neurol Neurosurg. 2012;114(7):981–985.
   PubMed Web of Science ®Google Scholar
• Öktem IS, Menku A, Özdemir A. When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus. Turk Neurosurg. 2008;18:387–391.
   PubMed Web of Science ®Google Scholar
• Northrup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr. 2000;30(10):313–332.
   PubMedGoogle Scholar
• Anegbe AO, Shokunbi MT, Oyemolade TA, et al. Intracranial infection in patients with myelomeningocele: profile and risk factors. Childs Nerv Syst. 2019;35(11):2205–2210.
   PubMed Web of Science ®Google Scholar
• Göçmez C, Çelik F, Tekin R, et al. Evaluation of risk factors affecting hospital-acquired infections in the neurosurgery intensive care unit. Int J Neurosci. 2014;124(7):503–508.
   PubMed Web of Science ®Google Scholar
• Müslüman AM, Karşıdağ S, Sucu DÖ, et al. Clinical outcomes of myelomeningocele defect closure over 10 years. J Clin Neurosci. 2012;19(7):984–990.
   PubMed Web of Science ®Google Scholar
• Forster CS, Courter J, Jackson EC. Frequency of multidrug-resistant organisms cultured from urine of children undergoing clean intermittent catheterization. J Pediatric Infect Dis Soc. 2017;6:332.
   PubMed Web of Science ®Google Scholar
• Aygün C, Kurucu S, Çakmak-Çelik F, et al. Experience of a tertiary care center on 100 newborns with neural tube defects. Turk J Pediatr. 2013;55(4):359–364.
   PubMed Web of Science ®Google Scholar
• Peyronnet B, Gao F, Brochard C, et al. Urologic disorders are still the leading cause of in-hospital death in patients with spina Bifida. Urology. 2020;137:200–204.
   PubMed Web of Science ®Google Scholar
• Walker O, Kenny CB, Goel N. Neonatal sepsis. Paediatr Child Health. 2019;29(6):263–268.
   Google Scholar
• Ertugrul S, Aktar F, Yolbas I, et al. Risk factors for health care-associated bloodstream infections in a neonatal intensive care unit. Iran J Pediatr. 2016;26(5):e5213.
   PubMed Web of Science ®Google Scholar
• Yorulmaz A, Konak M. Short-term results of patients with neural tube defects followed-up in the Konya region, Turkey. Birth Defects Res. 2019;111(5):261–269.
   PubMedGoogle Scholar